doi: 10.1016/j.neuroscience.2015.06.054 Summary Keywords Parkinsons disease, diabetes, glucagon-like peptide 1, insulin, energy metabolism, neuroprotection Citation Lv D, Feng P, Guan X, Liu Z, Li D, Xue C, Bai B and Hlscher C (2024) Neuroprotective effects of GLP-1 class drugs in Parkinsons disease
IODIDE METABOLISM AND EFFECTS Many patients with Hashimoto's thyroiditis do not respond to injected TSH with the expected increase in RAIU or release of hormone from the gland(81)
In their article, the researchers detail how these medications can both directly and indirectly reduce liver fat, inflammation, and fibrosis, potentially improving disease outcomes
Learn everything you need to know, including what it means and how to address digestive health for a happy gut